We are live on
!
Find out more
Clearstead Advisors Portfolio holdings
AUM
$10.6B
Turnover
42.91%
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
(-3.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2
years
Top 10 Avg Time Held Equity + Options
3
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
2
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.46% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
LoveSac
LOVE
$209M
| $418 | ﹤0.01% |
+25
| New | +$395 |
2026 Q2
0 quarters
|
|
2977
Lifeway Foods
LWAY
$334M
| $418 | ﹤0.01% |
14
| – | – |
2025 Q2
4 quarters
|
|
2978
MFA Financial
MFA
$666M
| $417 | ﹤0.01% |
+43
| New | +$417 |
2026 Q2
0 quarters
|
|
2979
Lithium Argentina AG
LAR
$760M
| $414 | ﹤0.01% |
50
| – | – |
2024 Q1
9 quarters
|
|
2980
BKV Corp
BKV
$2.51B
| $411 | ﹤0.01% |
+15
| New | +$413 |
2026 Q2
0 quarters
|
|
2981
Omega Flex
OFLX
$259M
| $409 | ﹤0.01% |
+13
| New | +$404 |
2026 Q2
0 quarters
|
|
2982
SI-BONE Inc
SIBN
$882M
| $409 | ﹤0.01% |
+25
| New | +$357 |
2026 Q2
0 quarters
|
|
2983
Shenandoah Telecom
SHEN
$570M
| $408 | ﹤0.01% |
+27
| New | +$425 |
2026 Q2
0 quarters
|
|
2984
TriMas Corp
TRS
$1.39B
| $407 | ﹤0.01% |
+9
| New | +$358 |
2026 Q2
0 quarters
|
|
2985
Fate Therapeutics
FATE
$214M
| $406 | ﹤0.01% |
+150
| New | +$278 |
2026 Q2
0 quarters
|
|
2986
AvePoint
AVPT
$3.03B
| $405 | ﹤0.01% |
+36
| New | +$370 |
2026 Q2
0 quarters
|
|
2987
NanoViricides
NNVC
$35.2M
| $405 | ﹤0.01% |
293
| – | – |
2022 Q2
16 quarters
|
|
2988
Conduent
CNDT
$216M
| $404 | ﹤0.01% |
276
+120
| +77% | +$186 |
2020 Q1
25 quarters
|
|
2989
Cogent Communications
CCOI
$413M
| $403 | ﹤0.01% |
+29
| New | +$535 |
2026 Q2
0 quarters
|
|
2990
Takeda Pharmaceutical
TAK
$62.8B
| $401 | ﹤0.01% |
25
| – | – |
2020 Q4
22 quarters
|
|
2991
HomeTrust Bancshares
HTB
$778M
| $400 | ﹤0.01% |
+8
| New | +$371 |
2026 Q2
0 quarters
|
|
2992
Editas Medicine
EDIT
$361M
| $399 | ﹤0.01% |
123
+98
| +392% | +$286 |
2021 Q1
21 quarters
|
|
2993
Travere Therapeutics
TVTX
$4.68B
| $399 | ﹤0.01% |
+7
| New | +$310 |
2026 Q2
0 quarters
|
|
2994
DHT Holdings
DHT
$3.81B
| $397 | ﹤0.01% |
+24
| New | +$429 |
2026 Q2
0 quarters
|
|
2995
Independent Bank Corp
IBCP
$790M
| $397 | ﹤0.01% |
+11
| New | +$376 |
2026 Q2
0 quarters
|
|
2996
DELISTED
BioLife Solutions
BLFS
| $396 | ﹤0.01% |
+14
| New | +$327 |
2026 Q2
0 quarters
|
|
2997
Enterprise Financial Services Corp
EFSC
$2.17B
| $396 | ﹤0.01% |
+6
| New | +$361 |
2026 Q2
0 quarters
|
|
2998
O-I Glass
OI
$896M
| $395 | ﹤0.01% |
+41
| New | +$386 |
2026 Q2
0 quarters
|
|
2999
Liquidity Services
LQDT
$1.37B
| $392 | ﹤0.01% |
+10
| New | +$354 |
2026 Q2
0 quarters
|
|
3000
Pursuit Attractions and Hospitality Inc
PRSU
$1.5B
| $392 | ﹤0.01% |
+7
| New | +$309 |
2026 Q2
0 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.